In the 2016 EpiPen pricing controversy, what pricing strategy did Mylan employ that caused public outrage when they increased the price from $100 to over $600?

In 2016, a major pharmaceutical company faced significant backlash after implementing a dramatic price increase on a life-saving medical device. This case study highlights the complex intersection of pricing strategies in medicine, public health needs, and corporate profit considerations. Test your knowledge about this famous pricing controversy that sparked national debate on healthcare affordability and pharmaceutical industry practices.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Price skimming - gradually lowering prices over time after initial high markup
Inelastic demand exploitation - dramatically raising prices on essential products with few substitutes
Loss leader pricing - selling EpiPens below cost to increase hospital contracts
Psychological pricing - setting prices just below round numbers to create perception of value